Skip to main content

Table 3 Characteristics of patients

From: Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)

Age Mean ± SD (range) 60 ± 17 y (22–81)
Leukocyte (109/L) 46 ± 44 (3.2–184)
FAB subtypes  
1 23% (7/31)
2 23% (7/31)
4 16% (5/31)
5 13% (4/31)
Myelodysplastic syndrome 26% (8/31)
Karyotype  
   Favorable 6% (2/31)
   Intermediate 71% (22/31)
   Poor 19% (6/31)
   Not done 3% (1/31)
CD34  
   Positive 55% (17/31)
   Negative 42% (13/31)
   Not done 3% (1/31)
P-gp activity  
   Mean D ± SD (range) 0.1 ± 0.1 (0–0.7)
   Positive D > 0.3 23% (7/31)
   Negative D < 0.3 77% (24/31)